Defymed

Developer of bio-artificial pancreas for diabetes type 1 treatment

placeStrasbourg, Grand Est, France calendar_todayFounded 2011 groups17 employees language defymed.com

Innovation

7 patent families (4 granted) — focus: Human necessities, Operations & transport; filing pace slowing. Cited 337 times.

YearFilings
20151
20162
20171
20183
20193
20204
20214
20222
20233

Investor mix

3 investors on record.

Investor typeCountShare
Private equity133%
Other / undisclosed267%
Coming soon